What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori ...
NTU solar leaf makes hydrogen from polluted seawater while cutting toxic hydrazine to 0.5 ppb, with limits explained plainly.
The Healthy @Reader's Digest on MSN
I went to a longevity clinic—here’s the surprising thing I learned about my health
One writer decided to investigate this trendy approach for herself, ultimately discovering a personal health red flag ...
A new critical review maps how light-activated photonanozymes are engineered, what they can catalyze, and the hurdles ...
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research ...
What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his ...
Scribe Therapeutics is initiated with a buy rating, targeting the in-vivo gene therapy market for cardiometabolic diseases.
Being able to 'see' laboratory values is different from being able to 'utilize' laboratory dataAs the electronic medical ...
Inventiva, Larimar Therapeutics, and Ascentage Pharma face key drug-development milestones, with analysts assigning Buy ...
The Hong Kong Science Museum (HKScM) is presenting the "2026 The Future Science Prize Exhibition" from today (October 16) to ...
Per- and polyfluoroalkyl substances, better known as PFAS, have earned the nickname "forever chemicals" for good reason. Their carbon–fluorine bonds, with dissociation energies of roughly 4 ...
City and Iambic Therapeutics raised $350M in IPOs, with shares surging above offer prices despite no commercial products or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results